Comparative Study
doi: 10.1126/science.6231724.
Antibodies to hepatitis B surface antigen potentiate the response of human T lymphocyte clones to the same antigen
- PMID: 6231724
- DOI: 10.1126/science.6231724
Item in Clipboard
Comparative Study
Antibodies to hepatitis B surface antigen potentiate the response of human T lymphocyte clones to the same antigen
Science.
.
Abstract
Human t-helper lymphocyte clones specific for hepatitis B virus surface antigen (HBsAg) proliferate on stimulation with HBsAg in vitro. Antibodies specific for HBsAg, but no other antibodies, augment this proliferative response. In the presence of antibodies to HBsAg, the maximum response could be achieved at HBsAg concentrations that were 1 percent of those required in the absence of the antibodies. These findings suggest that antigen-specific antibodies exert regulatory controls on T cells that recognize the same antigens.
Similar articles
-
Hepatitis B virus-reactive human T lymphocyte clones: antigen specificity and helper function for antibody synthesis.J Immunol. 1984 Mar;132(3):1511-6. J Immunol. 1984. PMID: 6198394
-
Human T cell clones reactive with hepatitis B virus (HBV) surface antigen from a HBV vaccine recipient.Gastroenterol Jpn. 1987 Apr;22(2):158-65. doi: 10.1007/BF02774212. Gastroenterol Jpn. 1987. PMID: 2954874
-
Deficient T-cell responses in non-responders to hepatitis B vaccination: absence of TH1 cytokine production.Immunol Lett. 1994 Feb;39(2):163-8. doi: 10.1016/0165-2478(94)90102-3. Immunol Lett. 1994. PMID: 8013962
-
Enhanced immunogenicity of hepatitis B surface antigen by insertion of a helper T cell epitope from tetanus toxoid.Vaccine. 1999 Mar 5;17(9-10):1035-41. doi: 10.1016/s0264-410x(98)00318-1. Vaccine. 1999. PMID: 10195612
-
Identification of T cell epitopes on hepatitis B surface antigen.Ann Ist Super Sanita. 1991;27(1):37-40. Ann Ist Super Sanita. 1991. PMID: 1720295 Review.
Cited by
-
Increasing Efficacy of Enveloped Whole-Virus Vaccines by In situ Immune-Complexing with the Natural Anti-Gal Antibody.Med Res Arch. 2021 Jul;9(7):2481. doi: 10.18103/mra.v9i7.2481. Epub 2021 Jul 10. Med Res Arch. 2021. PMID: 34853815 Free PMC article.
-
Self-Tumor Antigens in Solid Tumors Turned into Vaccines by α-gal Micelle Immunotherapy.Pharmaceutics. 2024 Sep 27;16(10):1263. doi: 10.3390/pharmaceutics16101263. Pharmaceutics. 2024. PMID: 39458595 Free PMC article. Review.
-
Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes.Vaccine. 2020 Sep 29;38(42):6487-6499. doi: 10.1016/j.vaccine.2020.08.032. Epub 2020 Aug 19. Vaccine. 2020. PMID: 32907757 Free PMC article. Review.
-
Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses preexisting immunity to enhance antigen-specific responses.J Clin Invest. 2023 Dec 1;133(23):e166827. doi: 10.1172/JCI166827. J Clin Invest. 2023. PMID: 38038133 Free PMC article.
-
Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants.Infect Immun. 2005 Sep;73(9):5915-22. doi: 10.1128/IAI.73.9.5915-5922.2005. Infect Immun. 2005. PMID: 16113311 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
